Global Submucosal Injections Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Submucosal Injections Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 88

Published Date: 11 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The submucosal injections are required principally during the endoscopic mucosal resection techniques.They are an indispensable part of endoscopic submucosal dissection. The most common submucosal injections were glucose water, hydroxypropyl methyl cellulose, normal saline, hyaluronic acid, hydroxyethyl starch and Orise gel.

According to our (Global Info Research) latest study, the global Submucosal Injections market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In recent years, there has been an increasing demand for endoscopic surgery, especially in developed economies.There has also been an increase in the number of patients seeking treatment for early gastric cancer or cancer in premature infants, which has contributed to the growth and demand for submucosal injections.All these factors will push the size of the submucosal injection market to expand
This report is a detailed and comprehensive analysis for global Submucosal Injections market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Submucosal Injections market size and forecasts, in consumption value ($ Million), 2018-2029
Global Submucosal Injections market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Submucosal Injections market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Submucosal Injections market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Submucosal Injections
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Submucosal Injections market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include COSMO PHARMACEUTICALS, Boston Scientific, Laborie(GI Supply), The Standard Co., Ltd. and EndoClot Plus, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Submucosal Injections market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
5 mL Syringe
10 mL Syringe

Market segment by Application
Endoscopic Mucosal Resection (EMR)
Endoscopic Submucosal Dissection (ESD)
Other

Market segment by players, this report covers
COSMO PHARMACEUTICALS
Boston Scientific
Laborie(GI Supply)
The Standard Co., Ltd.
EndoClot Plus, Inc.
Micro-Tech Endoscopy
Seikagaku

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Submucosal Injections product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Submucosal Injections, with revenue, gross margin and global market share of Submucosal Injections from 2018 to 2023.
Chapter 3, the Submucosal Injections competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Submucosal Injections market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Submucosal Injections.
Chapter 13, to describe Submucosal Injections research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Submucosal Injections
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Submucosal Injections by Type
1.3.1 Overview: Global Submucosal Injections Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Submucosal Injections Consumption Value Market Share by Type in 2022
1.3.3 5 mL Syringe
1.3.4 10 mL Syringe
1.4 Global Submucosal Injections Market by Application
1.4.1 Overview: Global Submucosal Injections Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Endoscopic Mucosal Resection (EMR)
1.4.3 Endoscopic Submucosal Dissection (ESD)
1.4.4 Other
1.5 Global Submucosal Injections Market Size & Forecast
1.6 Global Submucosal Injections Market Size and Forecast by Region
1.6.1 Global Submucosal Injections Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Submucosal Injections Market Size by Region, (2018-2029)
1.6.3 North America Submucosal Injections Market Size and Prospect (2018-2029)
1.6.4 Europe Submucosal Injections Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Submucosal Injections Market Size and Prospect (2018-2029)
1.6.6 South America Submucosal Injections Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Submucosal Injections Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 COSMO PHARMACEUTICALS
2.1.1 COSMO PHARMACEUTICALS Details
2.1.2 COSMO PHARMACEUTICALS Major Business
2.1.3 COSMO PHARMACEUTICALS Submucosal Injections Product and Solutions
2.1.4 COSMO PHARMACEUTICALS Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 COSMO PHARMACEUTICALS Recent Developments and Future Plans
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Submucosal Injections Product and Solutions
2.2.4 Boston Scientific Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boston Scientific Recent Developments and Future Plans
2.3 Laborie(GI Supply)
2.3.1 Laborie(GI Supply) Details
2.3.2 Laborie(GI Supply) Major Business
2.3.3 Laborie(GI Supply) Submucosal Injections Product and Solutions
2.3.4 Laborie(GI Supply) Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Laborie(GI Supply) Recent Developments and Future Plans
2.4 The Standard Co., Ltd.
2.4.1 The Standard Co., Ltd. Details
2.4.2 The Standard Co., Ltd. Major Business
2.4.3 The Standard Co., Ltd. Submucosal Injections Product and Solutions
2.4.4 The Standard Co., Ltd. Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 The Standard Co., Ltd. Recent Developments and Future Plans
2.5 EndoClot Plus, Inc.
2.5.1 EndoClot Plus, Inc. Details
2.5.2 EndoClot Plus, Inc. Major Business
2.5.3 EndoClot Plus, Inc. Submucosal Injections Product and Solutions
2.5.4 EndoClot Plus, Inc. Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 EndoClot Plus, Inc. Recent Developments and Future Plans
2.6 Micro-Tech Endoscopy
2.6.1 Micro-Tech Endoscopy Details
2.6.2 Micro-Tech Endoscopy Major Business
2.6.3 Micro-Tech Endoscopy Submucosal Injections Product and Solutions
2.6.4 Micro-Tech Endoscopy Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Micro-Tech Endoscopy Recent Developments and Future Plans
2.7 Seikagaku
2.7.1 Seikagaku Details
2.7.2 Seikagaku Major Business
2.7.3 Seikagaku Submucosal Injections Product and Solutions
2.7.4 Seikagaku Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Seikagaku Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Submucosal Injections Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Submucosal Injections by Company Revenue
3.2.2 Top 3 Submucosal Injections Players Market Share in 2022
3.2.3 Top 6 Submucosal Injections Players Market Share in 2022
3.3 Submucosal Injections Market: Overall Company Footprint Analysis
3.3.1 Submucosal Injections Market: Region Footprint
3.3.2 Submucosal Injections Market: Company Product Type Footprint
3.3.3 Submucosal Injections Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Submucosal Injections Consumption Value and Market Share by Type (2018-2023)
4.2 Global Submucosal Injections Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Submucosal Injections Consumption Value Market Share by Application (2018-2023)
5.2 Global Submucosal Injections Market Forecast by Application (2024-2029)

6 North America
6.1 North America Submucosal Injections Consumption Value by Type (2018-2029)
6.2 North America Submucosal Injections Consumption Value by Application (2018-2029)
6.3 North America Submucosal Injections Market Size by Country
6.3.1 North America Submucosal Injections Consumption Value by Country (2018-2029)
6.3.2 United States Submucosal Injections Market Size and Forecast (2018-2029)
6.3.3 Canada Submucosal Injections Market Size and Forecast (2018-2029)
6.3.4 Mexico Submucosal Injections Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Submucosal Injections Consumption Value by Type (2018-2029)
7.2 Europe Submucosal Injections Consumption Value by Application (2018-2029)
7.3 Europe Submucosal Injections Market Size by Country
7.3.1 Europe Submucosal Injections Consumption Value by Country (2018-2029)
7.3.2 Germany Submucosal Injections Market Size and Forecast (2018-2029)
7.3.3 France Submucosal Injections Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Submucosal Injections Market Size and Forecast (2018-2029)
7.3.5 Russia Submucosal Injections Market Size and Forecast (2018-2029)
7.3.6 Italy Submucosal Injections Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Submucosal Injections Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Submucosal Injections Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Submucosal Injections Market Size by Region
8.3.1 Asia-Pacific Submucosal Injections Consumption Value by Region (2018-2029)
8.3.2 China Submucosal Injections Market Size and Forecast (2018-2029)
8.3.3 Japan Submucosal Injections Market Size and Forecast (2018-2029)
8.3.4 South Korea Submucosal Injections Market Size and Forecast (2018-2029)
8.3.5 India Submucosal Injections Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Submucosal Injections Market Size and Forecast (2018-2029)
8.3.7 Australia Submucosal Injections Market Size and Forecast (2018-2029)

9 South America
9.1 South America Submucosal Injections Consumption Value by Type (2018-2029)
9.2 South America Submucosal Injections Consumption Value by Application (2018-2029)
9.3 South America Submucosal Injections Market Size by Country
9.3.1 South America Submucosal Injections Consumption Value by Country (2018-2029)
9.3.2 Brazil Submucosal Injections Market Size and Forecast (2018-2029)
9.3.3 Argentina Submucosal Injections Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Submucosal Injections Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Submucosal Injections Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Submucosal Injections Market Size by Country
10.3.1 Middle East & Africa Submucosal Injections Consumption Value by Country (2018-2029)
10.3.2 Turkey Submucosal Injections Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Submucosal Injections Market Size and Forecast (2018-2029)
10.3.4 UAE Submucosal Injections Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Submucosal Injections Market Drivers
11.2 Submucosal Injections Market Restraints
11.3 Submucosal Injections Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
12.1 Submucosal Injections Industry Chain
12.2 Submucosal Injections Upstream Analysis
12.3 Submucosal Injections Midstream Analysis
12.4 Submucosal Injections Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Submucosal Injections Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Submucosal Injections Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Submucosal Injections Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Submucosal Injections Consumption Value by Region (2024-2029) & (USD Million)
Table 5. COSMO PHARMACEUTICALS Company Information, Head Office, and Major Competitors
Table 6. COSMO PHARMACEUTICALS Major Business
Table 7. COSMO PHARMACEUTICALS Submucosal Injections Product and Solutions
Table 8. COSMO PHARMACEUTICALS Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. COSMO PHARMACEUTICALS Recent Developments and Future Plans
Table 10. Boston Scientific Company Information, Head Office, and Major Competitors
Table 11. Boston Scientific Major Business
Table 12. Boston Scientific Submucosal Injections Product and Solutions
Table 13. Boston Scientific Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Boston Scientific Recent Developments and Future Plans
Table 15. Laborie(GI Supply) Company Information, Head Office, and Major Competitors
Table 16. Laborie(GI Supply) Major Business
Table 17. Laborie(GI Supply) Submucosal Injections Product and Solutions
Table 18. Laborie(GI Supply) Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Laborie(GI Supply) Recent Developments and Future Plans
Table 20. The Standard Co., Ltd. Company Information, Head Office, and Major Competitors
Table 21. The Standard Co., Ltd. Major Business
Table 22. The Standard Co., Ltd. Submucosal Injections Product and Solutions
Table 23. The Standard Co., Ltd. Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. The Standard Co., Ltd. Recent Developments and Future Plans
Table 25. EndoClot Plus, Inc. Company Information, Head Office, and Major Competitors
Table 26. EndoClot Plus, Inc. Major Business
Table 27. EndoClot Plus, Inc. Submucosal Injections Product and Solutions
Table 28. EndoClot Plus, Inc. Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. EndoClot Plus, Inc. Recent Developments and Future Plans
Table 30. Micro-Tech Endoscopy Company Information, Head Office, and Major Competitors
Table 31. Micro-Tech Endoscopy Major Business
Table 32. Micro-Tech Endoscopy Submucosal Injections Product and Solutions
Table 33. Micro-Tech Endoscopy Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Micro-Tech Endoscopy Recent Developments and Future Plans
Table 35. Seikagaku Company Information, Head Office, and Major Competitors
Table 36. Seikagaku Major Business
Table 37. Seikagaku Submucosal Injections Product and Solutions
Table 38. Seikagaku Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Seikagaku Recent Developments and Future Plans
Table 40. Global Submucosal Injections Revenue (USD Million) by Players (2018-2023)
Table 41. Global Submucosal Injections Revenue Share by Players (2018-2023)
Table 42. Breakdown of Submucosal Injections by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in Submucosal Injections, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 44. Head Office of Key Submucosal Injections Players
Table 45. Submucosal Injections Market: Company Product Type Footprint
Table 46. Submucosal Injections Market: Company Product Application Footprint
Table 47. Submucosal Injections New Market Entrants and Barriers to Market Entry
Table 48. Submucosal Injections Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Submucosal Injections Consumption Value (USD Million) by Type (2018-2023)
Table 50. Global Submucosal Injections Consumption Value Share by Type (2018-2023)
Table 51. Global Submucosal Injections Consumption Value Forecast by Type (2024-2029)
Table 52. Global Submucosal Injections Consumption Value by Application (2018-2023)
Table 53. Global Submucosal Injections Consumption Value Forecast by Application (2024-2029)
Table 54. North America Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 55. North America Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 56. North America Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 57. North America Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 58. North America Submucosal Injections Consumption Value by Country (2018-2023) & (USD Million)
Table 59. North America Submucosal Injections Consumption Value by Country (2024-2029) & (USD Million)
Table 60. Europe Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Europe Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Europe Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 63. Europe Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 64. Europe Submucosal Injections Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Submucosal Injections Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 67. Asia-Pacific Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 68. Asia-Pacific Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 69. Asia-Pacific Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 70. Asia-Pacific Submucosal Injections Consumption Value by Region (2018-2023) & (USD Million)
Table 71. Asia-Pacific Submucosal Injections Consumption Value by Region (2024-2029) & (USD Million)
Table 72. South America Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 73. South America Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 74. South America Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 75. South America Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 76. South America Submucosal Injections Consumption Value by Country (2018-2023) & (USD Million)
Table 77. South America Submucosal Injections Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Middle East & Africa Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 79. Middle East & Africa Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 80. Middle East & Africa Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 81. Middle East & Africa Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 82. Middle East & Africa Submucosal Injections Consumption Value by Country (2018-2023) & (USD Million)
Table 83. Middle East & Africa Submucosal Injections Consumption Value by Country (2024-2029) & (USD Million)
Table 84. Submucosal Injections Raw Material
Table 85. Key Suppliers of Submucosal Injections Raw Materials
List of Figures
Figure 1. Submucosal Injections Picture
Figure 2. Global Submucosal Injections Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Submucosal Injections Consumption Value Market Share by Type in 2022
Figure 4. 5 mL Syringe
Figure 5. 10 mL Syringe
Figure 6. Global Submucosal Injections Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Submucosal Injections Consumption Value Market Share by Application in 2022
Figure 8. Endoscopic Mucosal Resection (EMR) Picture
Figure 9. Endoscopic Submucosal Dissection (ESD) Picture
Figure 10. Other Picture
Figure 11. Global Submucosal Injections Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Submucosal Injections Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Submucosal Injections Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Submucosal Injections Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Submucosal Injections Consumption Value Market Share by Region in 2022
Figure 16. North America Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Submucosal Injections Revenue Share by Players in 2022
Figure 22. Submucosal Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Submucosal Injections Market Share in 2022
Figure 24. Global Top 6 Players Submucosal Injections Market Share in 2022
Figure 25. Global Submucosal Injections Consumption Value Share by Type (2018-2023)
Figure 26. Global Submucosal Injections Market Share Forecast by Type (2024-2029)
Figure 27. Global Submucosal Injections Consumption Value Share by Application (2018-2023)
Figure 28. Global Submucosal Injections Market Share Forecast by Application (2024-2029)
Figure 29. North America Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Submucosal Injections Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Submucosal Injections Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 39. France Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Submucosal Injections Consumption Value Market Share by Region (2018-2029)
Figure 46. China Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 49. India Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Submucosal Injections Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Submucosal Injections Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 63. Submucosal Injections Market Drivers
Figure 64. Submucosal Injections Market Restraints
Figure 65. Submucosal Injections Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Submucosal Injections in 2022
Figure 68. Manufacturing Process Analysis of Submucosal Injections
Figure 69. Submucosal Injections Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

COSMO PHARMACEUTICALS
Boston Scientific
Laborie(GI Supply)
The Standard Co., Ltd.
EndoClot Plus, Inc.
Micro-Tech Endoscopy
Seikagaku
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Submucosal Injections Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Submucosal Injections Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 88

Published Date: 11 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The submucosal injections are required principally during the endoscopic mucosal resection techniques.They are an indispensable part of endoscopic submucosal dissection. The most common submucosal injections were glucose water, hydroxypropyl methyl cellulose, normal saline, hyaluronic acid, hydroxyethyl starch and Orise gel.

According to our (Global Info Research) latest study, the global Submucosal Injections market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In recent years, there has been an increasing demand for endoscopic surgery, especially in developed economies.There has also been an increase in the number of patients seeking treatment for early gastric cancer or cancer in premature infants, which has contributed to the growth and demand for submucosal injections.All these factors will push the size of the submucosal injection market to expand
This report is a detailed and comprehensive analysis for global Submucosal Injections market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Submucosal Injections market size and forecasts, in consumption value ($ Million), 2018-2029
Global Submucosal Injections market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Submucosal Injections market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Submucosal Injections market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Submucosal Injections
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Submucosal Injections market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include COSMO PHARMACEUTICALS, Boston Scientific, Laborie(GI Supply), The Standard Co., Ltd. and EndoClot Plus, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Submucosal Injections market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
5 mL Syringe
10 mL Syringe

Market segment by Application
Endoscopic Mucosal Resection (EMR)
Endoscopic Submucosal Dissection (ESD)
Other

Market segment by players, this report covers
COSMO PHARMACEUTICALS
Boston Scientific
Laborie(GI Supply)
The Standard Co., Ltd.
EndoClot Plus, Inc.
Micro-Tech Endoscopy
Seikagaku

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Submucosal Injections product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Submucosal Injections, with revenue, gross margin and global market share of Submucosal Injections from 2018 to 2023.
Chapter 3, the Submucosal Injections competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Submucosal Injections market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Submucosal Injections.
Chapter 13, to describe Submucosal Injections research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Submucosal Injections
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Submucosal Injections by Type
1.3.1 Overview: Global Submucosal Injections Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Submucosal Injections Consumption Value Market Share by Type in 2022
1.3.3 5 mL Syringe
1.3.4 10 mL Syringe
1.4 Global Submucosal Injections Market by Application
1.4.1 Overview: Global Submucosal Injections Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Endoscopic Mucosal Resection (EMR)
1.4.3 Endoscopic Submucosal Dissection (ESD)
1.4.4 Other
1.5 Global Submucosal Injections Market Size & Forecast
1.6 Global Submucosal Injections Market Size and Forecast by Region
1.6.1 Global Submucosal Injections Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Submucosal Injections Market Size by Region, (2018-2029)
1.6.3 North America Submucosal Injections Market Size and Prospect (2018-2029)
1.6.4 Europe Submucosal Injections Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Submucosal Injections Market Size and Prospect (2018-2029)
1.6.6 South America Submucosal Injections Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Submucosal Injections Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 COSMO PHARMACEUTICALS
2.1.1 COSMO PHARMACEUTICALS Details
2.1.2 COSMO PHARMACEUTICALS Major Business
2.1.3 COSMO PHARMACEUTICALS Submucosal Injections Product and Solutions
2.1.4 COSMO PHARMACEUTICALS Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 COSMO PHARMACEUTICALS Recent Developments and Future Plans
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Submucosal Injections Product and Solutions
2.2.4 Boston Scientific Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boston Scientific Recent Developments and Future Plans
2.3 Laborie(GI Supply)
2.3.1 Laborie(GI Supply) Details
2.3.2 Laborie(GI Supply) Major Business
2.3.3 Laborie(GI Supply) Submucosal Injections Product and Solutions
2.3.4 Laborie(GI Supply) Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Laborie(GI Supply) Recent Developments and Future Plans
2.4 The Standard Co., Ltd.
2.4.1 The Standard Co., Ltd. Details
2.4.2 The Standard Co., Ltd. Major Business
2.4.3 The Standard Co., Ltd. Submucosal Injections Product and Solutions
2.4.4 The Standard Co., Ltd. Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 The Standard Co., Ltd. Recent Developments and Future Plans
2.5 EndoClot Plus, Inc.
2.5.1 EndoClot Plus, Inc. Details
2.5.2 EndoClot Plus, Inc. Major Business
2.5.3 EndoClot Plus, Inc. Submucosal Injections Product and Solutions
2.5.4 EndoClot Plus, Inc. Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 EndoClot Plus, Inc. Recent Developments and Future Plans
2.6 Micro-Tech Endoscopy
2.6.1 Micro-Tech Endoscopy Details
2.6.2 Micro-Tech Endoscopy Major Business
2.6.3 Micro-Tech Endoscopy Submucosal Injections Product and Solutions
2.6.4 Micro-Tech Endoscopy Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Micro-Tech Endoscopy Recent Developments and Future Plans
2.7 Seikagaku
2.7.1 Seikagaku Details
2.7.2 Seikagaku Major Business
2.7.3 Seikagaku Submucosal Injections Product and Solutions
2.7.4 Seikagaku Submucosal Injections Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Seikagaku Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Submucosal Injections Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Submucosal Injections by Company Revenue
3.2.2 Top 3 Submucosal Injections Players Market Share in 2022
3.2.3 Top 6 Submucosal Injections Players Market Share in 2022
3.3 Submucosal Injections Market: Overall Company Footprint Analysis
3.3.1 Submucosal Injections Market: Region Footprint
3.3.2 Submucosal Injections Market: Company Product Type Footprint
3.3.3 Submucosal Injections Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Submucosal Injections Consumption Value and Market Share by Type (2018-2023)
4.2 Global Submucosal Injections Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Submucosal Injections Consumption Value Market Share by Application (2018-2023)
5.2 Global Submucosal Injections Market Forecast by Application (2024-2029)

6 North America
6.1 North America Submucosal Injections Consumption Value by Type (2018-2029)
6.2 North America Submucosal Injections Consumption Value by Application (2018-2029)
6.3 North America Submucosal Injections Market Size by Country
6.3.1 North America Submucosal Injections Consumption Value by Country (2018-2029)
6.3.2 United States Submucosal Injections Market Size and Forecast (2018-2029)
6.3.3 Canada Submucosal Injections Market Size and Forecast (2018-2029)
6.3.4 Mexico Submucosal Injections Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Submucosal Injections Consumption Value by Type (2018-2029)
7.2 Europe Submucosal Injections Consumption Value by Application (2018-2029)
7.3 Europe Submucosal Injections Market Size by Country
7.3.1 Europe Submucosal Injections Consumption Value by Country (2018-2029)
7.3.2 Germany Submucosal Injections Market Size and Forecast (2018-2029)
7.3.3 France Submucosal Injections Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Submucosal Injections Market Size and Forecast (2018-2029)
7.3.5 Russia Submucosal Injections Market Size and Forecast (2018-2029)
7.3.6 Italy Submucosal Injections Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Submucosal Injections Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Submucosal Injections Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Submucosal Injections Market Size by Region
8.3.1 Asia-Pacific Submucosal Injections Consumption Value by Region (2018-2029)
8.3.2 China Submucosal Injections Market Size and Forecast (2018-2029)
8.3.3 Japan Submucosal Injections Market Size and Forecast (2018-2029)
8.3.4 South Korea Submucosal Injections Market Size and Forecast (2018-2029)
8.3.5 India Submucosal Injections Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Submucosal Injections Market Size and Forecast (2018-2029)
8.3.7 Australia Submucosal Injections Market Size and Forecast (2018-2029)

9 South America
9.1 South America Submucosal Injections Consumption Value by Type (2018-2029)
9.2 South America Submucosal Injections Consumption Value by Application (2018-2029)
9.3 South America Submucosal Injections Market Size by Country
9.3.1 South America Submucosal Injections Consumption Value by Country (2018-2029)
9.3.2 Brazil Submucosal Injections Market Size and Forecast (2018-2029)
9.3.3 Argentina Submucosal Injections Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Submucosal Injections Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Submucosal Injections Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Submucosal Injections Market Size by Country
10.3.1 Middle East & Africa Submucosal Injections Consumption Value by Country (2018-2029)
10.3.2 Turkey Submucosal Injections Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Submucosal Injections Market Size and Forecast (2018-2029)
10.3.4 UAE Submucosal Injections Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Submucosal Injections Market Drivers
11.2 Submucosal Injections Market Restraints
11.3 Submucosal Injections Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
12.1 Submucosal Injections Industry Chain
12.2 Submucosal Injections Upstream Analysis
12.3 Submucosal Injections Midstream Analysis
12.4 Submucosal Injections Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Submucosal Injections Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Submucosal Injections Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Submucosal Injections Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Submucosal Injections Consumption Value by Region (2024-2029) & (USD Million)
Table 5. COSMO PHARMACEUTICALS Company Information, Head Office, and Major Competitors
Table 6. COSMO PHARMACEUTICALS Major Business
Table 7. COSMO PHARMACEUTICALS Submucosal Injections Product and Solutions
Table 8. COSMO PHARMACEUTICALS Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. COSMO PHARMACEUTICALS Recent Developments and Future Plans
Table 10. Boston Scientific Company Information, Head Office, and Major Competitors
Table 11. Boston Scientific Major Business
Table 12. Boston Scientific Submucosal Injections Product and Solutions
Table 13. Boston Scientific Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Boston Scientific Recent Developments and Future Plans
Table 15. Laborie(GI Supply) Company Information, Head Office, and Major Competitors
Table 16. Laborie(GI Supply) Major Business
Table 17. Laborie(GI Supply) Submucosal Injections Product and Solutions
Table 18. Laborie(GI Supply) Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Laborie(GI Supply) Recent Developments and Future Plans
Table 20. The Standard Co., Ltd. Company Information, Head Office, and Major Competitors
Table 21. The Standard Co., Ltd. Major Business
Table 22. The Standard Co., Ltd. Submucosal Injections Product and Solutions
Table 23. The Standard Co., Ltd. Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. The Standard Co., Ltd. Recent Developments and Future Plans
Table 25. EndoClot Plus, Inc. Company Information, Head Office, and Major Competitors
Table 26. EndoClot Plus, Inc. Major Business
Table 27. EndoClot Plus, Inc. Submucosal Injections Product and Solutions
Table 28. EndoClot Plus, Inc. Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. EndoClot Plus, Inc. Recent Developments and Future Plans
Table 30. Micro-Tech Endoscopy Company Information, Head Office, and Major Competitors
Table 31. Micro-Tech Endoscopy Major Business
Table 32. Micro-Tech Endoscopy Submucosal Injections Product and Solutions
Table 33. Micro-Tech Endoscopy Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Micro-Tech Endoscopy Recent Developments and Future Plans
Table 35. Seikagaku Company Information, Head Office, and Major Competitors
Table 36. Seikagaku Major Business
Table 37. Seikagaku Submucosal Injections Product and Solutions
Table 38. Seikagaku Submucosal Injections Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Seikagaku Recent Developments and Future Plans
Table 40. Global Submucosal Injections Revenue (USD Million) by Players (2018-2023)
Table 41. Global Submucosal Injections Revenue Share by Players (2018-2023)
Table 42. Breakdown of Submucosal Injections by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in Submucosal Injections, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 44. Head Office of Key Submucosal Injections Players
Table 45. Submucosal Injections Market: Company Product Type Footprint
Table 46. Submucosal Injections Market: Company Product Application Footprint
Table 47. Submucosal Injections New Market Entrants and Barriers to Market Entry
Table 48. Submucosal Injections Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Submucosal Injections Consumption Value (USD Million) by Type (2018-2023)
Table 50. Global Submucosal Injections Consumption Value Share by Type (2018-2023)
Table 51. Global Submucosal Injections Consumption Value Forecast by Type (2024-2029)
Table 52. Global Submucosal Injections Consumption Value by Application (2018-2023)
Table 53. Global Submucosal Injections Consumption Value Forecast by Application (2024-2029)
Table 54. North America Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 55. North America Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 56. North America Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 57. North America Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 58. North America Submucosal Injections Consumption Value by Country (2018-2023) & (USD Million)
Table 59. North America Submucosal Injections Consumption Value by Country (2024-2029) & (USD Million)
Table 60. Europe Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Europe Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Europe Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 63. Europe Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 64. Europe Submucosal Injections Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Submucosal Injections Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 67. Asia-Pacific Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 68. Asia-Pacific Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 69. Asia-Pacific Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 70. Asia-Pacific Submucosal Injections Consumption Value by Region (2018-2023) & (USD Million)
Table 71. Asia-Pacific Submucosal Injections Consumption Value by Region (2024-2029) & (USD Million)
Table 72. South America Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 73. South America Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 74. South America Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 75. South America Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 76. South America Submucosal Injections Consumption Value by Country (2018-2023) & (USD Million)
Table 77. South America Submucosal Injections Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Middle East & Africa Submucosal Injections Consumption Value by Type (2018-2023) & (USD Million)
Table 79. Middle East & Africa Submucosal Injections Consumption Value by Type (2024-2029) & (USD Million)
Table 80. Middle East & Africa Submucosal Injections Consumption Value by Application (2018-2023) & (USD Million)
Table 81. Middle East & Africa Submucosal Injections Consumption Value by Application (2024-2029) & (USD Million)
Table 82. Middle East & Africa Submucosal Injections Consumption Value by Country (2018-2023) & (USD Million)
Table 83. Middle East & Africa Submucosal Injections Consumption Value by Country (2024-2029) & (USD Million)
Table 84. Submucosal Injections Raw Material
Table 85. Key Suppliers of Submucosal Injections Raw Materials
List of Figures
Figure 1. Submucosal Injections Picture
Figure 2. Global Submucosal Injections Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Submucosal Injections Consumption Value Market Share by Type in 2022
Figure 4. 5 mL Syringe
Figure 5. 10 mL Syringe
Figure 6. Global Submucosal Injections Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Submucosal Injections Consumption Value Market Share by Application in 2022
Figure 8. Endoscopic Mucosal Resection (EMR) Picture
Figure 9. Endoscopic Submucosal Dissection (ESD) Picture
Figure 10. Other Picture
Figure 11. Global Submucosal Injections Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Submucosal Injections Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Submucosal Injections Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Submucosal Injections Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Submucosal Injections Consumption Value Market Share by Region in 2022
Figure 16. North America Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Submucosal Injections Revenue Share by Players in 2022
Figure 22. Submucosal Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Submucosal Injections Market Share in 2022
Figure 24. Global Top 6 Players Submucosal Injections Market Share in 2022
Figure 25. Global Submucosal Injections Consumption Value Share by Type (2018-2023)
Figure 26. Global Submucosal Injections Market Share Forecast by Type (2024-2029)
Figure 27. Global Submucosal Injections Consumption Value Share by Application (2018-2023)
Figure 28. Global Submucosal Injections Market Share Forecast by Application (2024-2029)
Figure 29. North America Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Submucosal Injections Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Submucosal Injections Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 39. France Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Submucosal Injections Consumption Value Market Share by Region (2018-2029)
Figure 46. China Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 49. India Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Submucosal Injections Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Submucosal Injections Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Submucosal Injections Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Submucosal Injections Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Submucosal Injections Consumption Value (2018-2029) & (USD Million)
Figure 63. Submucosal Injections Market Drivers
Figure 64. Submucosal Injections Market Restraints
Figure 65. Submucosal Injections Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Submucosal Injections in 2022
Figure 68. Manufacturing Process Analysis of Submucosal Injections
Figure 69. Submucosal Injections Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

COSMO PHARMACEUTICALS
Boston Scientific
Laborie(GI Supply)
The Standard Co., Ltd.
EndoClot Plus, Inc.
Micro-Tech Endoscopy
Seikagaku
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now